144 related articles for article (PubMed ID: 36193313)
1. Medical Data Analysis of CYP1B1 Gene Polymorphism and Clinical Prognosis of Minimally Invasive Surgery for Lung Cancer.
Han X; Li D; Zhang S
Biomed Res Int; 2022; 2022():5217625. PubMed ID: 36193313
[TBL] [Abstract][Full Text] [Related]
2. CYP1B1 Gene Polymorphism Based on Health Monitoring and Nursing Methods after Minimally Invasive Surgery for Lung Cancer.
Liu C; Liu B; Han X; Zhang Y
Contrast Media Mol Imaging; 2022; 2022():7042014. PubMed ID: 36128170
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients.
Vasile E; Tibaldi C; Leon GL; D'Incecco A; Giovannetti E
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1189-94. PubMed ID: 25504507
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
5. Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice.
Madeen EP; Löhr CV; You H; Siddens LK; Krueger SK; Dashwood RH; Gonzalez FJ; Baird WM; Ho E; Bramer L; Waters KM; Williams DE
Mol Carcinog; 2017 Jan; 56(1):163-171. PubMed ID: 26990437
[TBL] [Abstract][Full Text] [Related]
6. CYP1B1 G199T Polymorphism Affects Prognosis of NSCLC Patients with the Potential to Be an Indicator and Target for Precise Drug Intervention.
Li F; Zhang S; Zhang Q; Li J; Zhao S; Gu C
Biomed Res Int; 2017; 2017():1529564. PubMed ID: 28377924
[TBL] [Abstract][Full Text] [Related]
7. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image.
Zhang S; Li D; Han X
Open Life Sci; 2023; 18(1):20220688. PubMed ID: 37791062
[TBL] [Abstract][Full Text] [Related]
8. Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen.
Abdul Aziz AA; Md Salleh MS; Yahya MM; Zakaria AD; Ankathil R
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1319-1324. PubMed ID: 33906328
[TBL] [Abstract][Full Text] [Related]
9. Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis.
Lao X; Qin X; Peng Q; Chen Z; Lu Y; Liu Y; Li S
Lung; 2014 Oct; 192(5):739-48. PubMed ID: 24989113
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
11. Relationship between CYP1B1 polymorphisms (c.142C > G, c.355G > T, c.1294C > G) and lung cancer risk in Polish smokers.
Sawrycki P; Domagalski K; Cechowska M; Gąsior M; Jarkiewicz-Tretyn J; Tretyn A
Future Oncol; 2018 Jul; 14(16):1569-1577. PubMed ID: 29938532
[TBL] [Abstract][Full Text] [Related]
12. Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.
Liu JY; Yang Y; Liu ZZ; Xie JJ; Du YP; Wang W
Mol Genet Genomics; 2015 Apr; 290(2):739-65. PubMed ID: 25475389
[TBL] [Abstract][Full Text] [Related]
13. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
[TBL] [Abstract][Full Text] [Related]
14. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
Bailey LR; Roodi N; Dupont WD; Parl FF
Cancer Res; 1998 Nov; 58(22):5038-41. PubMed ID: 9823305
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
16. [Precise application of Traditional Chinese Medicine in minimally-invasive techniques].
Dong FH
Zhongguo Gu Shang; 2018 Jun; 31(6):493-496. PubMed ID: 29945400
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the invasive traits of breast cancers by CYP1B1 via regulation of p53 to promote uPAR expression.
Kwon YJ; Kwon TU; Shin S; Lee B; Lee H; Park H; Kim D; Moon A; Chun YJ
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166868. PubMed ID: 37661069
[TBL] [Abstract][Full Text] [Related]
19. Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.
Chen PF; He XF; Huang GH; Wang W; Qiu ZH
Technol Cancer Res Treat; 2016 Oct; 15(5):NP73-82. PubMed ID: 26283052
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]